Ryuji Kubota

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Mesenchymal Stem Cells

Patient Reported

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical drug investigation

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Daichi Yamaguchi, Ryosuke Shimizu, Ryuji Kubota
Development of a SARS-CoV-2 viral dynamic model for patients with COVID-19 based on the amount of viral RNA and viral titer. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Daichi Yamaguchi, Ryosuke Shimizu, Ryuji Kubota
Development of a SARS-CoV-2 viral dynamic model for patients with COVID-19 based on the amount of viral RNA and viral titer. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Daichi Yamaguchi, Ryosuke Shimizu, Ryuji Kubota
Development of a SARS-CoV-2 viral dynamic model for patients with COVID-19 based on the amount of viral RNA and viral titer. CPT: pharmacometrics & systems pharmacology (2024)
Daichi Yamaguchi, Ryosuke Shimizu, Ryuji Kubota
Development of a SARS-CoV-2 viral dynamic model for patients with COVID-19 based on the amount of viral RNA and viral titer. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Kazuya Fukumura, Nao Kawaguchi, Toru Ishibashi, Ryuji Kubota, Yukio Tada, Eriko Ogura
Clinical Drug-Drug Interaction Studies to Evaluate the Effects of a P-Glycoprotein Inhibitor, CYP3A Inhibitors, and a CYP3A Inducer on the Pharmacokinetics of Naldemedine in Healthy Subjects. Clinical drug investigation 40 (6) (2020)
Ryuji Kubota, Kazuya Fukumura, Toshihiro Wajima
Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine. Pharmaceutical research 35 (11) (2018)